FDA — authorised 6 November 2018
- Application: NDA209355
- Marketing authorisation holder: BAUSCH
- Local brand name: BRYHALI
- Indication: LOTION — TOPICAL
- Status: approved
FDA authorised Bryhali on 6 November 2018
Yes. FDA authorised it on 6 November 2018.
BAUSCH holds the US marketing authorisation.